PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

To boldly go where no glass has gone before

2012-04-04
(Press-News.org) QUT's first foray into space is bound to be a giant step for mankind.

Dr Martin Castillo from Queensland University of Technology's (QUT) Science and Engineering Faculty, and researcher for the university's micro-gravity drop tower, in Brisbane, Australia, has partnered with the United States Air Force to fund world-first research into the development of ZBLAN glass.

Dr Castillo said the special glass will be the first QUT project to be launched into space.

"True ZBLAN glass fibres can only be made in the absence of gravity," he said.

"This glass contains a variety of heavy metals that upon cooling create internal stresses which leads to crystallization of the material, an undesired property for glass.

"The synthesis of this material in the absence of gravity has the ability to overcome this barrier."

It is believed the glass could revolutionise the way we make fibres for telecommunications and medical imaging tools.

Dr Castillo said the glass has the lowest theoretical attenuation loss of any glass yet known to man, which means little or no loss in signal occurs within the material.

"This special glass can be potentially drawn into a solid fibre and signals would be able to be transmitted over much great distances than in current silicate glass fibres," he said.

"The result of this is potentially eliminating power consuming amplifiers and repeaters while significantly increasing bandwidth.

"Although this glass has been made in a few places, no one has yet figured out how to draw it into a fibre."

Research will first be conducted at QUT's micro-gravity drop tower in an experiment that will see the glass undergo ~2.1 seconds of microgravity over a 21.3 meter drop inside a drag shield.

Dr Castillo, who has previously worked for space programs in the United States and Japan, will then board NASA's parabolic flight plane, dubbed the 'vomit comet', before launching the project into space via a United States Air Force suborbital satellite by mid next year.

"In order to stay at the leading edge of the synthesis of specialised glass, all traditional methods have to be abandoned," Dr Castillo said.

"I previously spent two years working in Japan trying to produce this glass via gas levitation and with a fibre pulling apparatus in zero gravity and was unsuccessful.

"Now I think we've been able to formulate very new and different techniques to that used by anyone in the world."

INFORMATION:

Media contact: Alita Pashley, QUT media officer, 07 3138 1841 or alita.pashley@qut.edu.au

END



ELSE PRESS RELEASES FROM THIS DATE:

Fremantle's L-3 Nautronix Establishes Itself as a World Leader in the Commercial and Defence Sectors, in Manufacturing Digital

2012-04-04
Since its inception in 1984, L-3 Nautronix has established itself as a true global leader in the maritime manufacturing and defence sectors, supplying through-water communications, portable tracking devices, navigation tools and geospatial support systems to Australian and international maritime customers. Nautronix was originally founded just south of Perth in Fremantle, Western Australia to satisfy a niche oil and gas industry requirement: establishing offshore acoustic control and undersea positioning systems just off the west coast. The young company grew quickly, ...

Stopping the spread of a deadly childhood bone cancer

2012-04-04
CHICAGO -- Many children with the bone cancer, osteosarcoma, die after the tumor spreads to their lungs. In a critical step toward finding a way to stop metastasis, researchers at Georgetown Lombardi Comprehensive Cancer Center say they have discovered an agent that prevents this type of cancer from spreading to the lungs in mice with the disease. The new agent stops or inhibits "ezrin," a protein vital to the spread of osteosarcoma, say the researchers who presented their findings today at the American Association for Cancer Research (AACR) Annual Meeting 2012. If ...

Cholesterol drug shows benefit in animal study of Alzheimer's disease

2012-04-04
Washington, DC — A cholesterol drug commonly prescribed to reduce cardiovascular disease risk restores blood vessel function in a mouse model of Alzheimer's disease, according to a study in the April 4 issue of The Journal of Neuroscience. The drug simvastatin (Zocor®) — which works by slowing cholesterol production — also improves learning and memory in adult, but not aged Alzheimer's model mice. The findings add to a growing body of evidence that early treatment with statins protects against some of the symptoms of Alzheimer's disease. Alzheimer's disease destroys nerve ...

Former professional baseball pitcher now keeps his 'strike zone' in proteins

Former professional baseball pitcher now keeps his strike zone in proteins
2012-04-04
AMHERST, Mass. – Perhaps no other biochemist in the world has his own baseball card, but University of Massachusetts Amherst doctoral student Elih M. Velázquez-Delgado, who gave up a pitching career for science, does. Now the only stats he cares about are experimental data, because, he says, "I fell in love with the fact that I can see a molecule. I can actually see an enzyme and watch how it functions. That captured me." A native of Puerto Rico who pitched for five seasons in the minors, the Arizona and California Leagues, for the Oakland A's and San Francisco Giants' ...

Goldwind Australia Continues its Mission of 'Preserving White Clouds and Blue Skies for the Future', in the March Issue of Energy Digital

2012-04-04
Goldwind Australia is helping protect the nation's environmental future, one rotation at a time. China-based Goldwind Science and Technology Co became the world's fourth largest manufacturer of wind turbine generator technology by market share in 2010. Today, the company operates more than 11,000 turbines around the world (more than 15GW of installed capacity), and a majority of these machines are located in wind farms across China. The company has experienced rapid growth since its inception in 1998: between 2000 and 2009, Goldwind doubled its factory output every year. ...

Barker Boy Fresh Upholds Reputation of Providing Quality Pre-Prepared Australian Produce, in Food & Drink Digital

2012-04-04
Since 1986, Barker Boy Fresh has provided quality pre-prepared produce to Australians across the nation from its "clean and green" location in the Adelaide Hills. Over the course of its 25 year history, the company has earned itself a stellar reputation within the food production industry for its quality assurance and personable customer service, helping it to become one of South Australia's largest processors of produce. In the late 90s, Barker Boy built a new state of the art premises located in Mount Barker, South Australia and then a sister plant in the ...

Excess body weight associated with increased risk for prostate cancer recurrence

2012-04-04
CHICAGO -- Researchers have found an association between excess body weight and an increased risk for cancer recurrence in men with clinically localized prostate cancer. "Men diagnosed with early-stage prostate cancer and who have excess body weight as indicated by a higher-than-normal body mass index (BMI) have an increased risk for cancer recurrence after treatment," said Vincent L. Freeman, M.D., M.P.H., associate professor in the division of epidemiology and biostatistics in the School of Public Health at the University of Illinois in Chicago, Ill. Freeman presented ...

Noninvasive stool test for colorectal cancer unaffected by variables

2012-04-04
CHICAGO — Research on an investigational DNA methylation test for colorectal cancer demonstrated that the only clinical variable that influenced test results was age, according to results presented at the AACR Annual Meeting 2012, held here March 31 - April 4. "There was a progressive increase in background methylation levels that varied widely between methylation markers tested as a patient aged," said David Ahlquist, M.D., professor of medicine and a consultant in gastroenterology and hepatology at the Mayo Clinic in Rochester, Minn. "For example, median background ...

Caffeine and exercise may be protective against skin cancer caused by sun exposure

2012-04-04
CHICAGO — The combined effects of exercise plus caffeine consumption may be able to ward off skin cancer and also prevent inflammation related to other obesity-linked cancers. "We found that this combination treatment can decrease sunlight-caused skin cancer formation in a mouse model," said Yao-Ping Lu, Ph.D., associate research professor of chemical biology and director of skin cancer prevention at the Rutgers Ernest Mario School of Pharmacy in Piscataway, N.J. He presented these findings at the AACR Annual Meeting 2012, held here March 31 - April 4. "I believe we ...

Aerison Pty Ltd Supports Environmental Sustainability during Australia's Economic Boom, in Manufacturing Digital

2012-04-04
As the mining and resources industries fuel Australia's economic growth, companies such as Aerison Pty Ltd are working to lessen the impact of these projects on the environment. Since 1993, Western Australia-based Aerison has completed over 700 environmental projects ranging from air pollution and dust control solutions at mine sites to VOC destruction technology implementation and acoustic noise control systems at various mechanical facilities. Though the company was originally known as HPS Environmental, then as Enerflex Environmental in 2005, and finally as Aerison ...

LAST 30 PRESS RELEASES:

Weaving secondary battery electrodes with fibers and tying them like ropes for both durability and performance

Using social media may impair children’s attention

Science briefing: An update on GLP-1 drugs for obesity

Lower doses of immunotherapy for skin cancer give better results

Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

[Press-News.org] To boldly go where no glass has gone before